Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenAlex
Works that cite this article, indexed by OpenAlex.
Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome
The Journal of Infectious Diseases 216(suppl_8) (2017)
Di Wu; Qin Ning
The response to interferon is influenced by hepatitis B virus genotype in vitro and in vivo
Virus Research 171(1) (2012)
Yuhua Zhang; Yiqi Wu; Shengqian Ye; Tianzhen Wang; Ran Zhao; Fulai Chen; Kenji Abe; Xiaoming Jin
Effects of Antiviral Therapy on the Recurrence of Hepatocellular Carcinoma After Curative Resection or Liver Transplantation
Hepatitis Monthly 12(10) (2012)
Yan Du; Tong Su; Yibo Ding; Guangwen Cao
Is Universal HBV Vaccination of Healthcare Workers a Relevant Strategy in Developing Endemic Countries? The Case of a University Hospital in Niger
PLoS ONE 7(9) (2012)
Gérard Pellissier; Yazdan Yazdanpanah; Eric Omar Adehossi; William Tosini; Boubacar Madougou; Kaza Ibrahima; Isabelle Lolom; Sylvie LeGac; É. Rouveix; Karen Champenois; Christian Rabaud; Élisabeth Bouvet
Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma
World Journal of Gastroenterology 19(47) (2013)
Toru Ishikawa
Design, Synthesis, and Evaluation of Tetrahydropyrrolo[1,2-c]pyrimidines as Capsid Assembly Inhibitors for HBV Treatment
ACS Medicinal Chemistry Letters 8(9) (2017)
Xiaolin Li; Kai Zhou; Haiying He; Qiong Zhou; Ya Ping Sun; Lijuan Hou; Liang Shen; Xiaofei Wang; Yuedong Zhou; Zhen Long Gong; Shibo He; Huangtao Jin; Zhengxian Gu; Shuyong Zhao; Long Zhang; Chunyan Sun; Shansong Zheng; Zhe Cheng; Yidong Zhu; Minghui Zhang; Jian Li; Shuhui Chen
The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis
PLoS ONE 10(7) (2015)
Qiaoling Xie; Ying Zhu; Linghong Wu; Linlin Fu; Yan Xiang
Recent Advances in the Management of Chronic Hepatitis B Including Suppression of Hepatocellular Carcinoma by Entecavir and Interferon
Oncology 89(Suppl. 2) (2015)
Soo Ki Kim; Soo Ryang Kim; Susumu Imoto; Madoka Tohyama; Yumi Otono; Tomoko Tamura; Ke Ih Kim; Mana Kobayashi; Aya Ohtani; Kayo Sugimoto; Aya Mizuguchi; Yukiko Hiramatsu; Masatoshi Kudo
Anti-hepatitis B virus activity of α-DDB–DU, a novel nucleoside analogue, in vitro and in vivo
European Journal of Pharmacology 702(1-3) (2013)
Liyun Zheng; Limin Zang; Qinghua Yang; Wenquan Yu; Fang Xian-zhen; Yu-Hai Zhang; Xue‐Jie Zhao; Na Wan; Yueteng Zhang; Qingduan Wang; Junbiao Chang
Molecular interactions between PAMAM dendrimer and some medicines that suppress the growth of hepatitis virus (Adefovir, Entecavir, Telbivudine, Lamivudine, Tenofovir): a theoretical study
International nano letters. 9(3) (2019)
Masoomeh Bayat; Avat Arman Taherpour; Seyed Mohammad Elahi
Anti-hepatitis B Virus Activity of α-DDB-FNCG, a Novel Nucleoside-Biphenyldicarboxylate Compound In Vitro and In Vivo
Journal of Pharmacological Sciences 126(3) (2014)
Qinghua Yang; Xue‐Jie Zhao; Wenquan Yu; Wu He; Xianzhen Fang; Limin Zang; Na Wan; Qingduan Wang; Liyun Zheng; Junbiao Chang
Prolonged Combination Therapy is More Effective than Monotherapy in Management of Chronic Hepatitis B Patients With Sustained Virological Response: An Experience From a ‘Real-World’ Clinical Setting
Iranian Red Crescent Medical Journal 15(12) (2013)
En Qiang Chen; Lang Bai; Lan Lan Chen; Tao You Zhou; Ling Yao Du; Hong Tang
Hepatitis B Virus: Epidemiology and Clinical Features of Related Cancer
Springer eBooks (2014)
Michael Charles Kew